FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3031990704> ?p ?o ?g. }

• W3031990704 abstract "e15007 Background: Bispecific antibodies which tether T-cells to cancer cells, and additionally activate T-cell mediated killing, have shown promise in treating B-cell malignancies. Dose intensity, however, is limited by cytokine release from the activated T-cells. Side effects include fever, hypotension, and hypoxia. Methods: A novel type of bispecific antibody (IGM-2323) was constructed using the pentameric IgM framework. Recombinant IgM heavy chains and kappa light chains with high affinity variable domains derived from an anti-CD20 IgG, were co-expressed with a J-chain fused to anti-CD3 single chain Fv domain. IGM-2323 has 10 binding domains for CD20, and one binding domain for CD3. Results: IGM-2323 binds to the CD20 antigen with > 1000-fold increased avidity relative to an IgG antibody format. IGM-2323 in human cell cultures shows highly potent T cell dependent cytotoxicity (EC 50 20 pM), even on cells with very low cell surface expression of CD20, rituximab-resistant lymphoma cell lines, and patient derived CLL cells. Significantly, IGM-2323 exhibits vastly reduced cytokine release, with equivalent T cell dependent killing of CD20-expressing cancer cells, as compared to corresponding IgG-based T cell bispecifics made with the same binding domains. IGM-2323 mediated killing can occur at low T-cell/cancer cell ratios, as low as (1:5). In addition, IGM-2323 mediates complement dependent cytotoxicity (CDC) of CD20-expressing cells with > 100-fold higher potency than IgG. IgM-based bispecific (anti-CD20 x anti-CD3) completely depletes circulating B cells in cynomolgus monkeys at doses of > 300 µg per kg. Furthermore, durable depletion of B cells in spleen and lymphoid tissues was noted with multiple doses of > 1 mg/kg. Importantly, in these studies no observable adverse effects were seen, despite repeated doses at up to 25 mg/kg (the highest dose tested). Low levels of transiently increased circulating IL-6 and no increased levels of circulating TNF-α and IFN-γ were observed in these primate studies. Conclusions: These data indicate that IgM-based bispecifics can induce T cell engagement and very potent cytotoxicity that can be dissociated from cytokine release syndrome in the primate model. These preclinical data demonstrate the potential for broad application of this novel modular IgM-based bispecific antibody format. A Phase I dose-escalation study of IGM-2323 in patients with relapsed/refractory Non-Hodgkin’s lymphoma has been initiated (NCT04082936) and is currently enrolling patients." @default.
• W3031990704 created "2020-06-05" @default.
• W3031990704 creator A5002310962 @default.
• W3031990704 creator A5017007807 @default.
• W3031990704 creator A5027453053 @default.
• W3031990704 creator A5031272789 @default.
• W3031990704 creator A5038916698 @default.
• W3031990704 creator A5041967628 @default.
• W3031990704 creator A5044446743 @default.
• W3031990704 creator A5052898157 @default.
• W3031990704 creator A5053894992 @default.
• W3031990704 creator A5055263060 @default.
• W3031990704 creator A5062972206 @default.
• W3031990704 creator A5066392289 @default.
• W3031990704 creator A5076469507 @default.
• W3031990704 creator A5086315802 @default.
• W3031990704 creator A5086351451 @default.
• W3031990704 creator A5088115795 @default.
• W3031990704 date "2020-05-20" @default.
• W3031990704 modified "2023-10-06" @default.
• W3031990704 title "Lymphoma cell-killing activity and cytokine release by CD20-directed bispecific IgM antibody-based T-cell engager (IGM-2323)." @default.
• W3031990704 doi "https://doi.org/10.1200/jco.2020.38.15_suppl.e15007" @default.
• W3031990704 hasPublicationYear "2020" @default.
• W3031990704 type Work @default.
• W3031990704 sameAs 3031990704 @default.
• W3031990704 citedByCount "1" @default.
• W3031990704 countsByYear W30319907042020 @default.
• W3031990704 crossrefType "journal-article" @default.
• W3031990704 hasAuthorship W3031990704A5002310962 @default.
• W3031990704 hasAuthorship W3031990704A5017007807 @default.
• W3031990704 hasAuthorship W3031990704A5027453053 @default.
• W3031990704 hasAuthorship W3031990704A5031272789 @default.
• W3031990704 hasAuthorship W3031990704A5038916698 @default.
• W3031990704 hasAuthorship W3031990704A5041967628 @default.
• W3031990704 hasAuthorship W3031990704A5044446743 @default.
• W3031990704 hasAuthorship W3031990704A5052898157 @default.
• W3031990704 hasAuthorship W3031990704A5053894992 @default.
• W3031990704 hasAuthorship W3031990704A5055263060 @default.
• W3031990704 hasAuthorship W3031990704A5062972206 @default.
• W3031990704 hasAuthorship W3031990704A5066392289 @default.
• W3031990704 hasAuthorship W3031990704A5076469507 @default.
• W3031990704 hasAuthorship W3031990704A5086315802 @default.
• W3031990704 hasAuthorship W3031990704A5086351451 @default.
• W3031990704 hasAuthorship W3031990704A5088115795 @default.
• W3031990704 hasConcept C114684123 @default.
• W3031990704 hasConcept C147483822 @default.
• W3031990704 hasConcept C153911025 @default.
• W3031990704 hasConcept C159654299 @default.
• W3031990704 hasConcept C167672396 @default.
• W3031990704 hasConcept C18031839 @default.
• W3031990704 hasConcept C185592680 @default.
• W3031990704 hasConcept C203014093 @default.
• W3031990704 hasConcept C2776090121 @default.
• W3031990704 hasConcept C2778453870 @default.
• W3031990704 hasConcept C502942594 @default.
• W3031990704 hasConcept C86803240 @default.
• W3031990704 hasConcept C8891405 @default.
• W3031990704 hasConceptScore W3031990704C114684123 @default.
• W3031990704 hasConceptScore W3031990704C147483822 @default.
• W3031990704 hasConceptScore W3031990704C153911025 @default.
• W3031990704 hasConceptScore W3031990704C159654299 @default.
• W3031990704 hasConceptScore W3031990704C167672396 @default.
• W3031990704 hasConceptScore W3031990704C18031839 @default.
• W3031990704 hasConceptScore W3031990704C185592680 @default.
• W3031990704 hasConceptScore W3031990704C203014093 @default.
• W3031990704 hasConceptScore W3031990704C2776090121 @default.
• W3031990704 hasConceptScore W3031990704C2778453870 @default.
• W3031990704 hasConceptScore W3031990704C502942594 @default.
• W3031990704 hasConceptScore W3031990704C86803240 @default.
• W3031990704 hasConceptScore W3031990704C8891405 @default.
• W3031990704 hasLocation W30319907041 @default.
• W3031990704 hasOpenAccess W3031990704 @default.
• W3031990704 hasPrimaryLocation W30319907041 @default.
• W3031990704 hasRelatedWork W11482747 @default.
• W3031990704 hasRelatedWork W11737159 @default.
• W3031990704 hasRelatedWork W13304159 @default.
• W3031990704 hasRelatedWork W20970074 @default.
• W3031990704 hasRelatedWork W21209515 @default.
• W3031990704 hasRelatedWork W3477638 @default.
• W3031990704 hasRelatedWork W3492940 @default.
• W3031990704 hasRelatedWork W6940214 @default.
• W3031990704 hasRelatedWork W8018899 @default.
• W3031990704 hasRelatedWork W849381 @default.
• W3031990704 isParatext "false" @default.
• W3031990704 isRetracted "false" @default.
• W3031990704 magId "3031990704" @default.
• W3031990704 workType "article" @default.